NDUFB4P12

Across TCGA pan-cancer cohorts, NDUFB4P12 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated NDUFB4P12 data layer compared with 21 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher NDUFB4P12 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated NDUFB4P12 expression acts as an unfavorable survival marker.

HNSC, PDAC, and LUAD are the cancer types where NDUFB4P12 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Median	II,III,IV	0.900	0.992	.007	11	view →
PDAC	DFS	Median	All	0.190	0.472	.034	4	view →
LUAD	OS	Median	All	0.531	0.867	.040	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

NDUFB4P12–HNSC (DFS)

Open the HNSC breakdown →